Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor Immune Microenvironment and Immunotherapy in Brain Metastasis From Non-Small Cell Lung Cancer
Yu-Chang Wang, Rui Chen, Yue Wa, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Extracellular vesicle-derived LINC00482 induces microglial M2 polarization to facilitate brain metastasis of NSCLC
Wenwen Xu, Nishant Patel, Yuxia Deng, et al.
Cancer Letters (2023) Vol. 561, pp. 216146-216146
Closed Access | Times Cited: 25
Blocking the MIF-CD74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization
Lichao Liu, Jian Wang, Ying Wang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 12
Overcoming tyrosine kinase inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade
Minjie Fu, Jiaxu Zhao, Licheng Zhang, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1882-1897.e7
Closed Access | Times Cited: 10
Exploring the Molecular Tumor Microenvironment and Translational Biomarkers in Brain Metastases of Non-Small-Cell Lung Cancer
Jiexi Wen, Jie Zeng Yu, Catherine Liu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2044-2044
Open Access | Times Cited: 7
Immunotherapy and brain metastasis in lung cancer: connecting bench side science to the clinic
Alejandro Ríos-Hoyo, Edurne Arriola
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Low-dose radiotherapy effects the progression of anti-tumor response
Lei Gao, Anqi Zhang
Translational Oncology (2023) Vol. 35, pp. 101710-101710
Open Access | Times Cited: 13
Harnessing immunotherapy for brain metastases: insights into tumor–brain microenvironment interactions and emerging treatment modalities
Dairan Zhou, Zhenyu Gong, Dejun Wu, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 13
Assessment of PD‐L1 Expression in Non‐Small Cell Lung Cancers Using [68Ga]Ga‐DOTA‐WL12 PET/CT
Yanfei Wu, Dong Xu, Yue Gu, et al.
Small Methods (2024)
Closed Access | Times Cited: 5
G-CSF improving combined whole brain radiotherapy and immunotherapy prognosis of non-small cell lung cancer brain metastases
Shilan Luo, Peng Li, Anqi Zhang, et al.
International Immunopharmacology (2024) Vol. 130, pp. 111705-111705
Closed Access | Times Cited: 4
Immune response recalibration using immune therapy and biomimetic nano-therapy against high-grade gliomas and brain metastases
Puja Sandhbor, Geofrey John, Sakshi Bhat, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101021-101021
Open Access
Targeting the crosstalk between glutamine metabolism and tumor immune microenvironment for lung cancer immunotherapy
Jingyang Li, Xiang Li, Shaohui Wang, et al.
Deleted Journal (2025)
Open Access
Biological mechanisms and immunotherapy of brain metastases in non-small cell lung cancer
Shih Sheng Jiang, Fengzhu Guo, Lin Li
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189320-189320
Closed Access
A Literature Review on the Treatment of Patients with Brain Metastasis from Lung Adenocarcinoma after EGFR-TKI Resistance
雨欣 刘
Advances in Clinical Medicine (2025) Vol. 15, Iss. 04, pp. 3235-3241
Closed Access
Streptococcus pneumoniae infection is associated with Matrix Metalloproteinase-9 in Lung Cancer Progression and Brain Metastases
Lu Gao, Feng Jiang
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Therapeutic efficacy of TMTP1-modified EVs in overcoming bone metastasis and immune resistance in PIK3CA mutant NSCLC
Liwen Liu, Tanghesi Wuyun, Xin Sun, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Refining Lung Cancer Brain Metastasis Models for Spatiotemporal Dynamic Research and Personalized Therapy
Ying Chen, Ao Zhang, Jing-Rong Wang, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1588-1588
Open Access
Immunotherapy and biomarkers in patients with lung cancer with tuberculosis: Recent advances and future Directions
Ling Yang, Zhuang Li, Zhaoyang Ye, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107881-107881
Open Access | Times Cited: 9
Exploring the prognostic potential of m6A methylation regulators in low-grade glioma: implications for tumor microenvironment modulation
Honggang Wu, Siqi Chen, Ziliang Hu, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
The application of different machine learning models based on PET/CT images and EGFR in predicting brain metastasis of adenocarcinoma of the lung
Chao Kong, Xiaoyan Yin, Jingmin Zou, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Construction and validation of a TTN mutation associated immune prognostic model for evaluating immune microenvironment and outcomes of gastric cancer: An observational study
Ruyue Chen, Zengwu Yao, Lixin Jiang
Medicine (2024) Vol. 103, Iss. 29, pp. e38979-e38979
Open Access | Times Cited: 2
Development of brain metastases in non-small-cell lung cancer: high-risk features
Nolan Winslow, Jacqueline Boyle, William H. Miller, et al.
CNS Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Radioresistance and brain metastases: a review of the literature and applied perspective
Andrew Youssef, Arjun Sahgal, Sunit Das
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
The pathogenesis of idiopathic normal pressure hydrocephalus based on the understanding of AQP1 and AQP4
Zitong Zhao, Jian He, Yibing Chen, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 10
Immunotherapy-based therapy as a promising treatment for EGFR-mutant advanced non-small cell lung cancer patients after EGFR-TKI resistance
Jianghua Ding, Xinjing Ding, Zhaohui Leng
Expert Review of Anticancer Therapy (2023) Vol. 23, Iss. 2, pp. 187-198
Closed Access | Times Cited: 6
HNRNPD is a prognostic biomarker in non-small cell lung cancer and affects tumor growth and metastasis via the PI3K-AKT pathway
Guoqing Fan, Danni Li, Jingjing Liu, et al.
Biotechnology and Genetic Engineering Reviews (2023) Vol. 40, Iss. 3, pp. 1571-1590
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top